Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

While the exact mechanism is unknown, the data suggest a multitude of benefits independent of large weight loss.

(GLP-1 receptor agonists are also called GLP-1 drugs or GLP-1 medications for short.) The way a drug works is known medically as its mechanism of action. The mechanism of action for Victoza may ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Lexicon Pharmaceuticals’ pursuit of the last word in obesity candidates has attracted Novo Nordisk. | Lexicon Pharmaceuticals ...